On June 18, 2026, in Vancouver, British Columbia, Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company utilizing its unique Diffusphere™ technology for targeted drug delivery, shared outcomes of its recent Annual General Meeting of Shareholders.